BFRIW
Biofrontera Inc.
Key Financials
Operating Income
$-11348000
↑ 34.1%
Total Assets
$28.6M
↑ 29.2%
Net Income
$-10536000
↑ 40.7%
EPS (Diluted)
$-1.04
↑ 67.7%
Revenue
$41.7M
↑ 11.7%
Total Liabilities
$18.1M
↑ 2.4%
Shareholders' Equity
$10.5M
↑ 136.4%
Cash & Equivalents
$6.4M
↑ 8.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/14/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| 10-K | 3/19/2026 | View on SEC |
| 8-K | 3/19/2026 | View on SEC |
| 8-K | 3/9/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BFRIW |
| Company Name | Biofrontera Inc. |
| CIK | 1858685 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-245-1325 |